In a large study of postmenopausal women, those who had ever taken a short-acting calcium channel blocker (CCB) saw their pancreatic cancer risk shoot up by 66 percent.



from WebMD Health https://ift.tt/2vv2S0G

Related Posts:

0 comments:

Post a Comment

Popular Posts